Dozens of prescription and over-the-counter medications can cause shortness of breath, and they do it through surprisingly different mechanisms. Some drugs damage lung tissue directly, others slow the brain’s drive to breathe, and still others trigger fluid buildup, blood clots, or airway spasm. Drug-induced lung disease accounts for roughly 3 to 5 percent of all interstitial lung disease cases, and the list of possible culprits spans nearly every corner of the pharmacy, from heart medications and chemotherapy agents to common antibiotics and pain relievers.1PubMed Central. Drug-induced lung disease: a narrative review Understanding which drugs carry this risk, and how they cause breathing trouble, can help you recognize the problem early and get help before serious damage sets in.
Heart and Blood Pressure Medications
Cardiovascular drugs are among the most widely prescribed medications on earth, and several classes can affect breathing. Beta-blockers are the most obvious concern, particularly for people with asthma. These drugs block the receptors that help relax airway smooth muscle, and in people whose airways are already twitchy, that can provoke an asthma attack. A network meta-analysis of randomized controlled trials found that oral timolol and intravenous propranolol were linked to significantly higher rates of asthma attacks compared with placebo. In people with a known history of asthma, the list grew longer: oral labetalol, oxprenolol, propranolol, and metoprolol all showed elevated risk.2PubMed Central. Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials
Cardioselective beta-blockers, which target the heart more than the lungs, appear safer. A meta-analysis covering 19 single-dose and 10 continued-dose placebo-controlled trials in people with reactive airways found no meaningful difference in lung function, respiratory symptoms, or inhaler use when patients took cardioselective agents.3ERJ Open Research. The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports That said, “safer” is not the same as “risk-free,” and doctors still tend to monitor asthma patients closely when starting any beta-blocker.
ACE inhibitors, the blood pressure drugs whose names end in “-pril” (lisinopril, enalapril, ramipril), are famous for causing a persistent dry cough. The cough happens because ACE normally breaks down a substance called bradykinin; when you block the enzyme, bradykinin accumulates in the airways, sensitizes nerve fibers, and triggers cough and sometimes a feeling of tightness.4CHEST. Angiotensin-Converting Enzyme Inhibitor-Induced Cough In some people, the buildup goes further: bradykinin stimulates airway smooth muscle to constrict, leading to frank bronchoconstriction on top of the cough.5PubMed Central. ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction If you develop a nagging cough or mild breathlessness after starting an ACE inhibitor, it is worth mentioning to your prescriber; switching to an ARB (a related class that does not accumulate bradykinin) usually resolves the problem within weeks.
Amiodarone and Antiarrhythmic Drugs
Amiodarone, used to control dangerous heart rhythm disorders, is one of the best-known lung-toxic medications. It concentrates in lung tissue at levels far above what’s found in the blood, and over time it can trigger an inflammatory reaction called amiodarone pulmonary toxicity. This usually shows up as pneumonitis, with diffuse infiltrates visible on chest imaging.6PubMed Central. Amiodarone pulmonary toxicity The tricky part is that the onset can range from weeks to years after starting the drug, and early symptoms, such as gradually worsening shortness of breath, dry cough, and low-grade fever, can be mistaken for a chest infection or heart failure progression. Anyone on amiodarone should have periodic lung function monitoring, and worsening breathlessness should never be dismissed as just “getting older.”
Chemotherapy and Cancer Drugs
Cancer treatment is a major source of drug-induced breathing problems, and the mechanisms vary depending on the drug class.
Traditional Chemotherapy
Bleomycin, used in certain lymphoma and testicular cancer regimens, is the classic example. It damages lung cells through oxidative stress and triggers an inflammatory cascade that can progress to pulmonary fibrosis, a permanent scarring of lung tissue that stiffens the lungs and makes it harder to exchange oxygen.7PubMed. Mechanisms of bleomycin-induced lung damage Research in animal models has shown that bleomycin also injures the blood vessel lining inside the lungs, ramping up the production of fibrosis-promoting signals like TGF-β and connective tissue growth factor.8PubMed Central. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis The risk is dose-dependent, and oncologists track cumulative exposure carefully. Patients who have received bleomycin are also warned to tell anesthesiologists before any surgery, because high-concentration oxygen during anesthesia can worsen the lung damage.
Targeted Therapies
Newer cancer drugs aimed at specific molecular targets can also harm the lungs. EGFR tyrosine kinase inhibitors such as gefitinib and erlotinib, used mainly in non-small cell lung cancer, can cause interstitial lung disease.9PubMed Central. Molecular mechanisms of lung-specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors mTOR inhibitors, another targeted class, carry an even higher rate: up to about one in six patients develops a reversible interstitial pneumonitis.10PubMed. Pulmonary toxicities from targeted therapies: a review The word “reversible” is encouraging, but it depends on catching it early and stopping the drug promptly.
Immune Checkpoint Inhibitors
Immunotherapy drugs like pembrolizumab, nivolumab, and ipilimumab work by releasing the brakes on your immune system so it attacks cancer cells. The downside is that the unleashed immune system sometimes attacks normal lung tissue too. Immune checkpoint inhibitor pneumonitis is relatively uncommon, but when it occurs it can force a delay or permanent stop to treatment, and severe cases can be fatal.11PubMed Central. Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer The immune attack involves an increase in activated T cells in the lungs along with reduced activity of the anti-inflammatory regulatory T cells that normally keep things in check. In rare cases, immune checkpoint inhibitors have even caused necrotizing myositis of the diaphragm, essentially destroying the main breathing muscle itself and leading to respiratory failure.12PubMed Central. Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
Pain Medications
Opioids
Opioids are probably the most dangerous drugs for breathing in terms of immediate life-threatening risk. They suppress the brainstem circuits that generate and regulate your breathing rhythm. The effect shows up mainly as a slower breathing rate rather than shallower breaths, though both can occur.13PubMed Central. Multi-Level Regulation of Opioid-Induced Respiratory Depression The receptors involved, called mu-opioid receptors, sit in multiple brain regions tied to breathing, including the inspiratory rhythm generator and the areas that help you switch between inhaling and exhaling.14PubMed. Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effects Opioids also blunt the brain’s response to rising carbon dioxide levels, which is the normal alarm signal that makes you breathe faster. This means a person in opioid-induced respiratory depression may not feel short of breath in the usual panicky way; they may simply stop breathing adequately, sometimes during sleep.
Research in mouse models has shown that opioids suppress the firing of these respiratory neurons without silencing them completely, suggesting the effect is a graded dimming of the breathing drive rather than an on-off switch.15eLife. Dual mechanisms of opioid-induced respiratory depression in the inspiratory rhythm-generating network The risk climbs when opioids are combined with other sedating drugs like benzodiazepines or alcohol, both of which further depress the breathing drive through their own pathways.
NSAIDs and Aspirin
Aspirin and other nonsteroidal anti-inflammatory drugs do not typically cause breathing trouble in most people, but in a susceptible subset of asthma patients they can trigger severe bronchospasm, runny nose, and nasal congestion. The reaction stems from blocking an enzyme called cyclooxygenase-1, which shifts the body’s inflammatory chemistry toward overproduction of cysteinyl leukotrienes, powerful molecules that constrict airways.16PubMed. Mechanisms of aspirin sensitivity This condition, known as aspirin-exacerbated respiratory disease, affects a meaningful minority of people with asthma and nasal polyps. The leukotriene overproduction involves a partnership between platelets and white blood cells that converts precursor molecules into the active bronchoconstrictors.17PubMed Central. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes If you have asthma and notice worsening wheezing after taking ibuprofen or aspirin, this reaction is worth investigating with an allergist.
Methotrexate and Other Immunosuppressants
Methotrexate is a cornerstone treatment for rheumatoid arthritis, psoriasis, and several other autoimmune conditions. While most patients tolerate it well, lung toxicity is a well-recognized complication. The classic presentation is shortness of breath, a dry cough, fatigue, and fever, sometimes with diffuse infiltrates on chest imaging.18PubMed. Methotrexate pulmonary toxicity Cases have been reported at both high and low doses, and the pneumonitis does not always follow a predictable timeline.19PubMed Central. Methotrexate-induced pulmonary toxicity The good news is that methotrexate pneumonitis usually improves once the drug is stopped, especially if caught before significant scarring develops. The bad news is that the symptoms look a lot like a lung infection, which is also more likely in someone taking an immunosuppressant, so figuring out the cause can be tricky.
Antibiotics That Can Harm the Lungs
Nitrofurantoin, a widely prescribed antibiotic for urinary tract infections, is an underappreciated cause of drug-induced lung injury. It can trigger two distinct patterns: an acute hypersensitivity reaction that appears within days of starting the drug, and a chronic reaction involving fibrosis that develops over months to years of use.20PubMed Central. Nitrofurantoin-Induced Lung Injury: A Reminder of an Overlooked Threat The acute form can mimic pneumonia, with cough, breathlessness, bilateral crackles on exam, and infiltrates on chest X-ray. In one reported case, an 88-year-old woman developed dyspnea and bilateral airspace infiltrates just three days after starting nitrofurantoin for a UTI, with blood work showing elevated eosinophils suggesting an allergic-type reaction. Her symptoms improved shortly after the drug was stopped.21PubMed. Nitrofurantoin-induced pulmonary toxicity: A case report and review of the literature Because nitrofurantoin is sometimes prescribed as long-term low-dose prophylaxis for recurrent UTIs, the chronic fibrotic form is a real concern for older adults who may be on it for months or years.
Hormonal Medications and Blood Clot Risk
Some drugs cause breathlessness not by damaging the lungs directly but by promoting blood clots that travel to the lungs. Combined oral contraceptives containing estrogen are the most familiar example. Estrogen increases the blood’s tendency to clot, and in some women this leads to deep vein thrombosis followed by pulmonary embolism, a clot in the lung arteries that can cause sudden chest pain and shortness of breath.22PubMed Central. Double bad luck: pulmonary embolism and vaginal bleeding – a case report Hormone replacement therapy and certain fertility medications carry a similar risk. The breathlessness in a pulmonary embolism tends to come on suddenly, often with pleuritic chest pain that worsens with deep breathing, which is a different pattern from the gradual onset seen with most other drug-induced lung problems.
Diabetes Medications and Fluid Retention
Thiazolidinediones, the diabetes drugs pioglitazone and rosiglitazone, can cause fluid retention that sometimes tips into heart failure. They increase sodium and water reabsorption in the kidneys, leading to edema and, in susceptible patients, fluid accumulation in the lungs.23PubMed Central. Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms This does not mean the drugs poison the lung tissue the way bleomycin or amiodarone do. Instead, the breathing trouble comes from the heart’s inability to pump the extra fluid, leading to congestion. Patients with pre-existing heart failure are at the highest risk, which is why these drugs carry a boxed warning against use in that population.
Antiplatelet Drugs
Ticagrelor, a blood thinner commonly prescribed after heart attacks and stent placements, causes dyspnea in a meaningful fraction of patients. The breathlessness is usually mild and occurs at rest or with minimal exertion, and it often resolves after a few weeks even if you keep taking the drug. The mechanism appears to involve ticagrelor’s inhibition of a transporter called ENT1, which normally clears adenosine from the bloodstream. By blocking this transporter, ticagrelor raises local adenosine levels, and adenosine is known to stimulate sensory nerve fibers in the lungs that create a sensation of breathlessness.24PubMed. Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1 Other antiplatelet drugs in the same family, like clopidogrel and prasugrel, do not share this effect because they do not block ENT1. If ticagrelor-related breathlessness is bothersome, switching to prasugrel (when appropriate for your cardiac risk) usually eliminates it.
When Inhalers Make Breathing Worse
It sounds paradoxical, but the very inhalers designed to open your airways can occasionally cause them to clamp down. Paradoxical bronchospasm has been reported with beta-2 agonist metered-dose inhalers, and it can happen for several reasons: an IgE-mediated allergic reaction to excipients like soya bean lecithin, irritation from propellants or preservatives, or simply turbulent airflow from poor inhaler technique.25PubMed Central. Paradoxical bronchospasm: a rare adverse effect of fenoterol use This reaction may affect up to 8 percent of patients using beta-2 agonist inhalers.26PubMed Central. Paradoxical Bronchoconstriction with Short-Acting Beta Agonist
One preservative deserves special attention. Benzalkonium chloride, found in multi-dose albuterol nebulizer solutions, can cause cumulative bronchoconstriction that worsens with repeated doses. In one case, a 17-year-old patient received multiple nebulizer treatments over three and a half days without improving; peak flow remained stuck at about a quarter of predicted. Within two hours of switching to a benzalkonium-free formulation, her breathing dramatically improved and her peak flow more than doubled.27PubMed Central. Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma The lesson: if your inhaler or nebulizer seems to be making things worse rather than better, the problem may be the formulation, not the active drug.
Drugs That Weaken Breathing Muscles
A less obvious way for drugs to cause shortness of breath is by impairing the muscles you use to breathe. Over 100 drugs have been identified that can impair muscle function through various pathways: suppressing nerve signals, damaging peripheral nerves, blocking the junction between nerves and muscles, triggering autoimmune attacks on muscle tissue, or causing direct muscle toxicity.28PubMed. Adverse effects of drugs on the respiratory muscles Aminoglycoside antibiotics, for example, can block neuromuscular transmission, and this effect matters most in the operating room or in patients who already have conditions like myasthenia gravis. Long-term corticosteroid use can cause a steroid myopathy that weakens the diaphragm. The breathing difficulty from muscle weakness tends to be worse when lying flat, because gravity is no longer helping the diaphragm descend, and it often shows up as unexplained orthopnea or an inability to take a satisfying deep breath.
How Drug-Induced Breathing Problems Are Diagnosed
Pinning shortness of breath on a medication is largely a process of elimination. Consensus diagnostic criteria for drug-induced lung injury follow a logical sequence: the patient was taking a drug known to cause lung injury, the clinical presentation matches patterns reported with that drug, other causes have been ruled out, symptoms improve after stopping the drug, and (in rare cases where rechallenge is safe) symptoms return if the drug is restarted.29Respiratory Investigation. Consensus statement for the diagnosis and treatment of drug-induced lung injuries There is no single blood test or imaging sign that definitively says “this drug did it.” CT scans often show ground-glass opacities, consolidation, or patterns like organizing pneumonia, but these findings overlap with infections, autoimmune disease, and other causes.1PubMed Central. Drug-induced lung disease: a narrative review
The timing varies enormously. Drug-induced lung injury can appear anywhere from days to months after starting treatment, and occasionally even longer with cumulative-dose drugs like amiodarone and nitrofurantoin. This wide window makes it easy to overlook the medication as the culprit, especially when a patient is on multiple drugs and has other conditions that could explain their symptoms. If you develop new or worsening shortness of breath after starting any medication, the most useful thing you can do is tell your doctor exactly when the breathing trouble began relative to starting or changing your medications. That timeline is often the single best diagnostic clue.
Drugs People Forget to Mention
One underappreciated wrinkle: patients often do not think to report supplements, over-the-counter medications, or recreational substances when asked about their drug history. Herbal products, high-dose vitamin preparations, and illicit substances can all affect the lungs, yet they rarely come up in a standard medication review. Eye drops also catch people off guard. Timolol eye drops for glaucoma, for instance, are absorbed systemically in small amounts, and in people with asthma that small amount of a non-selective beta-blocker can be enough to provoke airway constriction. The network meta-analysis that flagged oral timolol as a risk also underscores why eye-drop formulations of the same drug carry respiratory warnings.2PubMed Central. Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials If you are being evaluated for unexplained breathlessness, bring a full list of everything you take, including eye drops, inhalers, supplements, and anything used occasionally rather than daily.